Home >> Life Sciences >> Pharmaceuticals

EMEA (Europe, Middle East and Africa) Epinephrine Market 2017 Forecast to 2022

Published: Jan-2018 | Format: PDF | Global Info Research | Number of pages: 118 | Code: MRS - 201189

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.


Scope of the Report:
This report focuses on the Epinephrine in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Mylan Inc
    Sanofi SA
    Impax
    ALK Abello
    Lincoln Medical Ltd
    AMPHASTAR

Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
    Epinephrine Auto-injector
    Epinephrine Prefilled Syringe
    Others

Market Segment by Applications, can be divided into
    Anaphylaxis
    Others

There are 13 Chapters to deeply display the EMEA Epinephrine market.

Chapter 1, to describe Epinephrine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Epinephrine, with sales, revenue, and price of Epinephrine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Epinephrine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Epinephrine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Epinephrine research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Table of Contents
1 Market Overview
    1.1 Epinephrine Introduction
    1.2 Market Analysis by Type
        1.2.1 Epinephrine Auto-injector
        1.2.2 Epinephrine Prefilled Syringe
        1.2.3 Others
    1.3 Market Analysis by Applications
        1.3.1 Anaphylaxis
        1.3.2 Others
    1.4 Market Analysis by Regions
        1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
            1.4.1.1 Germany Market States and Outlook (2012-2022)
            1.4.1.2 France Market States and Outlook (2012-2022)
            1.4.1.3 UK Market States and Outlook (2012-2022)
            1.4.1.4 Italy Market States and Outlook (2012-2022)
            1.4.1.5 Russia Market States and Outlook (2012-2022)
            1.4.1.6 Turkey Market States and Outlook (2012-2022)
        1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
            1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.2.2 UAE Market States and Outlook (2012-2022)
            1.4.2.3 Israel Market States and Outlook (2012-2022)
            1.4.2.4 Iran Market States and Outlook (2012-2022)
        1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
            1.4.3.1 South Africa Market States and Outlook (2012-2022)
            1.4.3.2 Nigeria Market States and Outlook (2012-2022)
            1.4.3.3 Egypt Market States and Outlook (2012-2022)
            1.4.3.4 Algeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Mylan Inc
        2.1.1 Business Overview
        2.1.2 Epinephrine Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Mylan Inc Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Sanofi SA
        2.2.1 Business Overview
        2.2.2 Epinephrine Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Sanofi SA Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Impax
        2.3.1 Business Overview
        2.3.2 Epinephrine Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Impax Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 ALK Abello
        2.4.1 Business Overview
        2.4.2 Epinephrine Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 ALK Abello Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Lincoln Medical Ltd
        2.5.1 Business Overview
        2.5.2 Epinephrine Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Lincoln Medical Ltd Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 AMPHASTAR
        2.6.1 Business Overview
        2.6.2 Epinephrine Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 AMPHASTAR Epinephrine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA Epinephrine Market Competition, by Manufacturer
    3.1 EMEA Epinephrine Sales and Market Share by Manufacturer
    3.2 EMEA Epinephrine Revenue and Market Share by Manufacturer
    3.3 EMEA Epinephrine Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Epinephrine Manufacturer Market Share
        3.4.2 Top 5 Epinephrine Manufacturer Market Share
    3.5 Market Competition Trend
4 EMEA Epinephrine Market Analysis by Regions
    4.1 EMEA Epinephrine Sales, Revenue and Market Share by Regions
        4.1.1 EMEA Epinephrine Sales by Regions (2012-2017)
        4.1.2 EMEA Epinephrine Revenue by Regions (2012-2017)
    4.2 Europe Epinephrine Sales and Growth (2012-2017)
    4.3 Middle East Epinephrine Sales and Growth (2012-2017)
    4.4 Africa Epinephrine Sales and Growth (2012-2017)
5 Europe Epinephrine by Countries, Type, Application and Manufacturers
    5.1 Europe Epinephrine Sales, Revenue and Market Share by Countries
        5.1.1 Europe Epinephrine Sales by Countries (2012-2017)
        5.1.2 Europe Epinephrine Revenue by Countries (2012-2017)
        5.1.3 Germany Epinephrine Sales and Growth (2012-2017)
        5.1.4 France Epinephrine Sales and Growth (2012-2017)
        5.1.5 UK Epinephrine Sales and Growth (2012-2017)
        5.1.6 Russia Epinephrine Sales and Growth (2012-2017)
        5.1.7 Italy Epinephrine Sales and Growth (2012-2017)
        5.1.8 Turkey Epinephrine Sales and Growth (2012-2017)
    5.2 Europe Epinephrine Sales and Revenue (value) by Manufacturers (2016-2017)
        5.2.1 Europe Epinephrine Sales by Manufacturers (2016-2017)
        5.2.2 Europe Epinephrine Revenue by Manufacturers (2016-2017)
    5.3 Europe Epinephrine Sales by Type (2012-2017)
    5.4 Europe Epinephrine Sales by Application (2012-2017)
6 Middle East Epinephrine by Countries, Type, Application and Manufacturers
    6.1 Middle East Epinephrine Sales, Revenue and Market Share by Countries
        6.1.1 Middle East Epinephrine Sales by Countries (2012-2017)
        6.1.2 Middle East Epinephrine Revenue by Countries (2012-2017)
        6.1.3 Saudi Arabia Epinephrine Sales and Growth (2012-2017)
        6.1.4 Israel Epinephrine Sales and Growth (2012-2017)
        6.1.5 UAE Epinephrine Sales and Growth (2012-2017)
        6.1.6 Iran Epinephrine Sales and Growth (2012-2017)
    6.2 Middle East Epinephrine Sales and Revenue (value) by Manufacturers (2016-2017)
        6.2.1 Middle East Epinephrine Sales by Manufacturers (2016-2017)
        6.2.2 Middle East Epinephrine Revenue by Manufacturers (2016-2017)
    6.3 Middle East Epinephrine Sales by Type (2012-2017)
    6.4 Middle East Epinephrine Sales by Application (2012-2017)
7 Africa Epinephrine by Countries, Type, Application and Manufacturers
    7.1 Africa Epinephrine Sales, Revenue and Market Share by Countries
        7.1.1 Africa Epinephrine Sales by Countries (2012-2017)
        7.1.2 Africa Epinephrine Revenue by Countries (2012-2017)
        7.1.3 South Africa Epinephrine Sales and Growth (2012-2017)
        7.1.4 Nigeria Epinephrine Sales and Growth (2012-2017)
        7.1.5 Egypt Epinephrine Sales and Growth (2012-2017)
        7.1.6 Algeria Epinephrine Sales and Growth (2012-2017)
    7.2 Middle East Epinephrine Sales and Revenue (value) by Manufacturers (2016-2017)
        7.2.1 Middle East Epinephrine Sales by Manufacturers (2016-2017)
        7.2.2 Middle East Epinephrine Revenue by Manufacturers (2016-2017)
    7.3 Middle East Epinephrine Sales by Type (2012-2017)
    7.4 Middle East Epinephrine Sales by Application (2012-2017)
8 EMEA Epinephrine Market Segment by Type
    8.1 EMEA Epinephrine Sales, Revenue and Market Share by Type (2012-2017)
        8.1.1 EMEA Epinephrine Sales and Market Share by Type (2012-2017)
        8.1.2 EMEA Epinephrine Revenue and Market Share by Type (2012-2017)
    8.2 Epinephrine Auto-injector Sales Growth and Price
        10.2.1 EMEA Epinephrine Auto-injector Sales Growth (2012-2017)
        10.2.2 EMEA Epinephrine Auto-injector Price (2012-2017)
    8.3 Epinephrine Prefilled Syringe Sales Growth and Price
        10.3.1 EMEA Epinephrine Prefilled Syringe Sales Growth (2012-2017)
        10.3.2 EMEA Epinephrine Prefilled Syringe Price (2012-2017)
    8.4 Others Sales Growth and Price
        10.4.1 EMEA Others Sales Growth (2012-2017)
        10.4.2 EMEA Others Price (2012-2017)
9 EMEA Epinephrine Market Segment by Application
    9.1 EMEA Epinephrine Sales Market Share by Application (2012-2017)
    9.2 Anaphylaxis Sales Growth (2012-2017)
    9.3 Others Sales Growth (2012-2017)
10 EMEA Epinephrine Market Forecast (2017-2022)
    10.1 EMEA Epinephrine Sales, Revenue and Growth Rate (2017-2022)
    10.2 Epinephrine Market Forecast by Regions (2017-2022)
        10.2.1 Europe Epinephrine Market Forecast by Regions (2017-2022)
            10.2.1.1 Germany Epinephrine Sales Forecast 2017-2022
            10.2.1.2 France Epinephrine Sales Forecast 2017-2022
            10.2.1.3 UK Epinephrine Sales Forecast 2017-2022
            10.2.1.4 Russia Epinephrine Sales Forecast 2017-2022
            10.2.1.5 Italy Epinephrine Sales Forecast 2017-2022
            10.2.1.6 Turkey Epinephrine Sales Forecast 2017-2022
        10.2.2 Middle East Market Forecast by Regions (2017-2022)
            10.2.2.1 Saudi Arabia Epinephrine Sales Forecast 2017-2022
            10.2.2.2 Israel Epinephrine Sales Forecast 2017-2022
            10.2.2.3 UAE Epinephrine Sales Forecast 2017-2022
            10.2.2.4 Iran Epinephrine Sales Forecast 2017-2022
        10.2.3 Africa Market Forecast by Regions (2017-2022)
            10.2.3.1 South Africa Epinephrine Sales Forecast 2017-2022
            10.2.3.2 Nigeria Epinephrine Sales Forecast 2017-2022
            10.2.3.3 Egypt Epinephrine Sales Forecast 2017-2022
            10.2.3.4 Algeria Epinephrine Sales Forecast 2017-2022
    10.3 Epinephrine Market Forecast by Type (2017-2022)
    10.4 Epinephrine Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
    11.1 Sales Channel
        11.1.1 Direct Marketing
        11.1.2 Indirect Marketing
        11.1.3 Marketing Channel Future Trend
    11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
    13.1 Methodology
    13.2 Analyst Introduction
    13.3 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

North America and Europe Active Pharmaceutical Ingredients Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-216951 | 4480

This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical sub Read more

North America and Europe Botox Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-216950 | 4480

Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in North America and Euro Read more

EMEA (Europe, Middle East and Africa) Vegetable Capsules Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 124 | Code : MRS-214954 | 4480

Pill is a common part of many people’s lives for pharmaceutical use or as health Supplements, It has two main forms of tablets and capsules. Tablets were the most popular way to take medicine for quite some time. While since some characters such as hard to swallow and slice, too many additives and so on, most people tend to switch to capsules from the industrialization era on when capsule shells technologies and filling machines have been developed. Scope of the Report: This report fo Read more

EMEA (Europe, Middle East and Africa) Sugar Sphere Market Professional Survey Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-214864 | 4480

Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere Market Professional Survey in EMEA market, covering Europe, Middle East and Africa, This report c Read more

Global Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-214050 | 3480

This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical sub Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gene Synthesis Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 105 | Code : MRS-214049 | 4880

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built. Sco Read more

Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-214048 | 3480

Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in global market, especia Read more

Global Pharmaceutical Hot Melt Extruder Market Research Report by Product Type, Application, Regions and Outlook 2017-2023

Jan-2018 | HeyReport | Pages : 77 | Code : MRS-213925 | 2030

Summary The global Pharmaceutical Hot Melt Extruder market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows: Read more

2018-2023 United States Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213213 | 3360

In 2017, the Neurofeedback System market size was xx million in United States, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemo Read more

2018-2023 UK Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213212 | 3360

In 2017, the Neurofeedback System market size was xx million in UK, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemoencephalographic (HEG) Read more

Single User | $(USD)4480 View Pricing